Market Alert: Strong Nuclear Tensions in South Asia Assessing the Fallout on Global Equity Markets
Highlights:
Significant Increase in Housing Lending
Calidus Resources Limited (ASX: CAI) and its subsidiaries have named Richard Tucker and John Bumbak of KordaMentha as Receivers and Managers following the appointment of Voluntary Administrators by Calidus' Board of Directors on June 28, 2024, by Macmahon Holdings Limited (ASX: MAH). As of June 28, 2024, Macmahon has a net current exposure of about NZ$33.9 million to Calidus at the Warrawoona mine, plus an additional NZ$5.7 million in Calidus equity shares.
Rising Mortgage Values
A total of NZ$6.9 billion was lent on new mortgages in May, marking the highest monthly total since March 2022. The overall mortgage stock, including bank and non-bank lenders, rose to NZ$360.603 billion, with an annual growth rate increasing from 3.1% in April to 3.3% in May, the largest annual rise since March of the previous year.
Banks vs. Non-Bank Lenders
Non-bank lenders saw a decrease in outstanding mortgage stock, dropping to NZ$5.9 billion in May from NZ$6 billion in April. Conversely, banks experienced a significant increase, with their outstanding mortgage stock rising by NZ$1.3 billion to NZ$354.6 billion, the most considerable monthly rise since January 2022. Non-performing loans slightly increased to NZ$1.91 billion in May from NZ$1.901 billion in April, with a yearly increase of NZ$675 million.
Trends in Bank Switching
The number of mortgage holders switching banks surged in May, likely seeking better deals amid rising job losses and living costs. Mortgage switches increased by 31% compared to the previous year and by 34% from April, involving NZ$1.655 billion in loans with an average size of NZ$636,500.
First Home Buyers and Investors
First home buyers’ share of new mortgages rose to 21.4% in May, a slight increase from April but a drop from 24.3% in May last year. Investors’ share decreased to 18.9% from 20.1% in April but increased from 16.9% the previous year. Owner-occupiers continued to dominate, with their share rising to 58.3% from 57.3% in April.
In total, 18,348 mortgages were written in May, a 16.7% increase from April and a 12.9% rise from May last year. The average new loan value marginally increased to NZ$376,553, up 4.5% from a year ago.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Apr 24, 2025
Apr 24, 2025
Apr 23, 2025
Apr 23, 2025
Apr 22, 2025
Apr 22, 2025
Apr 17, 2025
Apr 17, 2025
Apr 16, 2025
Apr 16, 2025
The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.